Position in ARQT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$25,380,409
-$516,503 QoQ
Shares Held
1,077,267
+20.8% QoQ
Ownership
0.861%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FEDERATED HERMES, INC. holds $2,364,625,345 across 146 Biotechnology names. ARQT ranks #31 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
687,816 | $227,577,679 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
254,946 | $196,981,475 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,286,303 | $111,869,771 | |
| 4 | MRNA |
Moderna, Inc.
|
1,977,079 | $100,435,613 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
2,987,107 | $99,530,405 | |
| 6 | INSM |
INSMED Inc
|
538,257 | $88,015,784 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
2,049,439 | $81,403,717 | |
| 8 | EYPT |
EyePoint, Inc.
|
5,669,589 | $73,081,000 |
All Filings in ARQT
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,380,409 | 1,077,267 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $25,896,912 | 891,767 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $14,317,950 | 759,573 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $10,337,911 | 737,369 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $11,535,359 | 737,555 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $6,866,401 | 492,922 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,667,026 | 501,831 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,256,060 | 350,114 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $3,469,629 | 350,114 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,684,344 | 521,469 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $318,600 | 60,000 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $381,200 | 40,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $330,000 | 30,000 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $355,200 | 24,000 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||